drugset / Trial / NCT02929342

Study to Assess the Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]-Pitolisant in Healthy Male Volunteers

NCT02929342

Phase 1 Completed 8 enrolled Bioprojet
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to better define the absorption and elimination pathways, and circulating metabolites of Pitolisant at steady state using Pitolisant radiolabelled, in healthy CYP2D6 genotyped male subject.

Timeline

Start
2016-07
Primary completion
2016-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Pitolisant Small molecule Oral

Indications

No indication recorded.